Table 1.
Characteristic of the study group.
Parameters | LTx patients | Normal range |
---|---|---|
N (male/female) | 14 (6/8) | – |
Age [years] | 32.0±14.2 | – |
WC [cm] | 75.0±4.1 [70.5–78.8]* | – |
HC [cm] | 88.1±6.4 | – |
BMI [kg/m2] | 18.0±1.5 [17.0–20.1]* | 18.5–24.99 |
RBC [×106/ul] | 4.6±0.86 | 4.5–5.9 |
WBC [×103/ul] | 15.7±8.08 | 4.3–10 |
HGB [mmol/l] | 8.1±1.35 | 8.7–11.2 |
PLT [×103/ul] | 176.5±84.75 [127.3–296.8]* | 150–350 |
INR | 1.2±0.23 | 0.85–1.3 |
AST [U/l] | 23.0±5.38 [17.5–28.3]* | 10–34 |
ALT [U/l] | 15.5±5.75 [12.0–23.5]* | 6–44 |
GGTP [U/l] | 16.0±12.13 [10.0–34.3]* | 5–61 |
Cr [μmol/l] | 62.2±24.48 | 62–106 |
HDL [mmol/l] | 0.3±0.13 [0.2–0.5]* | 0.9–1.7 |
LDL [mmol/l] | 1.8±0.87 | 1.3–3.36 |
TG [mmol/l] | 2.5±1.37 | 0.4–1.82 |
Protein [g/l] | 75.3±15.09 | 60–80 |
Albumin [g/l] | 36.9±8.52 | 35–50 |
CRP [mg/l] | 12.6±14.58 | <5 |
Distance in 6MWT [m] | 332.0±128.8 | – |
FEV1%N | 25.3±17.51 [20.0–55.0]* | 80–120 |
FVC%N | 53.4±23.5 | 80–120 |
Median ±quartile deviation [lower-upper quartile];
WC – waist circumstance; HC – hip circumference; FEV1 – Forced Expiratory Volume; FVC – Forced Vital Capacity; %N – the percentage of a due value.